Influenza B lineage circulation and hospitalization rates in a Subtropical City, Hong Kong, 2000-2010

Clinical Infectious Diseases

Volumn 56, Issue 5, 2013, Pages 677-684

  Chan, Paul K S ^a,b   Chan, Martin C W ^a   Cheung, Jo L K ^a   Lee, Nelson ^b   Leung, Ting F ^b   Yeung, Apple C M ^a   Wong, Martin C S ^b   Ngai, Karry L K ^a   Nelson, E Anthony S ^b   Hui, David S C ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

hospitalisation; influenza; lineage; Victoria; Yamagata

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; GROUPS BY AGE; HONG KONG; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA A; INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; GENES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HONG KONG; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PHYLOGENY; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VACCINATION; YOUNG ADULT;

EID: 84873680888     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis885     Document Type: Article

References (31)

1. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990; 175:59-68.
2. Chen JM, Guo YJ, Wu KY, et al. Exploration of the emergence of the Victoria lineage of influenza B virus. Arch Virol 2007; 152:415-22.
3. World Health Organization position paper: influenza vaccines. Wkly Epidemiol Rec 2005; 80:279-87.
4. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012; 8:81-8.
5. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010; 28:2149-56.
6. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8.
7. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010; 28(suppl 4):D45-53.
8. Hong Kong Resident population, Census and Statistics Department, The Government of Hong Kong Special Administrative Region. Available at: http://www.censtatd.gov.hk/hkstat/sub/sp440.jsp?productCode=B1120051. Accessed 19 October 2012.
9. Chi XS, Bolar TV, Zhao P, Rappaport R, Cheng SM. Cocirculation and evolution of two lineages of influenza B viruses in Europe and Israel in the 2001-2002 season. J Clin Microbiol 2003; 41:5770-3.
10. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28:2731-9.
11. Chan PK, Mok HY, Lee TC, Chu IM, Lam WY, Sung JJ. Seasonal influenza activity in Hong Kong and its association with meteorological variations. J Med Virol 2009; 81:1797-806.
12. Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol Infect 1998; 121:121-8.
13. Dosseh A, Ndiaye K, Spiegel A, Sagna M, Mathiot C. Epidemiological and virological influenza survey in Dakar, Senegal: 1996-1998. Am J Trop Med Hyg 2000; 62:639-43.
14. Russell CA, Jones TC, Barr IG, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008; 26(suppl 4):D31-4.
15. Nelson MI, Simonsen L, Viboud C, Miller MA, Holmes EC. Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog 2007; 3:1220-8.
16. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008; 453:615-9.
17. Tang JW, Ngai KL, Lam WY, Chan PK. Seasonality of influenza A (H3N2) virus: a Hong Kong perspective (1997-2006). PLoS One 2008; 3:e2768.
18. Chen GW, Shih SR, Hsiao MR, et al. Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol 2007; 45:1515-22.
19. Centers for Disease Control and Prevention. Seasonal influenza activity surveillance reports: 1999-2000 to 2010-2011 seasons. Available at: http://www.cdc.gov/flu/weekly/pastreports.htm. Accessed 25 June 2012.
20. World Health Organization. WHO/Europe influenza surveillance. Available at: http://www.euroflu.org/index.php. Accessed 25 June 2012.
21. Grant KA, Carville K, Fielding JE, et al. High proportion of influenza B characterises the 2008 influenza season in Victoria. Commun Dis Intell 2009; 33:328-36.
22. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
23. Bodewes R, de Mutsert G, van der Klis FR, et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 2011; 18:469-76.
24. Zhou H, Thompson WW, Viboud CG, et al. Hospitalisations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012; 54:1427-36.
25. Iskander M, Kesson A, Dwyer D, et al. The burden of influenza in children under 5 years admitted to the Children's Hospital at Westmead in the winter of 2006. J Paediatr Child Health 2009; 45:698-703.
26. Chiu SS, Chan KH, So LY, Chen R, Chan EL, Peiris JS. The population based socioeconomic burden of pediatric influenza-associated hospitalisation in Hong Kong. Vaccine 2012; 30:1895-900.
27. Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis 2010; 202:1626-33.
28. Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010; 303:943-50.
29. Block SL, Falloon J, Hirschfield JA, et al. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Pediatr Infect Dis J 2012; 31:745-51.
30. Block SL, Yi T, Sheldon E, Dubovsky F, Falloon J. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults. Vaccine 2011; 29:9391-7.
31. Della Cioppa G, Vesikari T, Sokal E, Lindert K, Nicolay U. Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose-and schedule-finding study. Vaccine 2011; 29:8696-704.